Cargando…

Development of a Method of Measuring β-D-Glucan and Its Use in Preemptive Therapy for Invasive Fungal Infections

Invasive fungal infections (IFIs) are serious infections that develop in conjunction with neutropenia after chemotherapy for acute leukemia or with hematopoietic stem cell transplantation. Conventionally, empirical antifungal therapy was recommended to treat IFIs for patient safety despite a lack of...

Descripción completa

Detalles Bibliográficos
Autor principal:	Yoshida, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431658/ https://www.ncbi.nlm.nih.gov/pubmed/34502174 http://dx.doi.org/10.3390/ijms22179265

Ejemplares similares

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study
por: Hanson, Kimberly E., et al.
Publicado: (2012)

Analysis of (1→3) β-d-glucan as a diagnostic adjunct for invasive fungal infections in the ICU setting
por: Yamada, N, et al.
Publicado: (2012)

Efficacy of the new β-D-glucan measurement kit for diagnosing invasive fungal infections, as compared with that of four conventional kits
por: Bamba, Yuuki, et al.
Publicado: (2021)

(1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs)
por: Fontana, C, et al.
Publicado: (2012)

Detection of (1,3)-β-d-Glucan for the Diagnosis of Invasive Fungal Infection in Liver Transplant Recipients
por: Levesque, Eric, et al.
Publicado: (2017)

Serum 1,3-βD-Glucan assay in the diagnosis of invasive fungal disease in neonates
por: Mackay, Cheryl Anne, et al.
Publicado: (2011)

Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease
por: Finkelman, Malcolm A.
Publicado: (2020)

Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2019)

(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies
por: Azoulay, Elie, et al.
Publicado: (2016)

2044. Utility of Serum Β-D Glucan Assay for Diagnosis of Invasive Fungal Infections in Solid Organ Transplant Recipients
por: Vijayvargiya, Prakhar, et al.
Publicado: (2018)

1701. Differences in Diagnostic Performance of β-d-Glucan Testing in Patients with Varying Degrees of Susceptibility to Invasive Fungal Infections
por: Nham, Eliel, et al.
Publicado: (2019)

2043. T2-Candida (T2MR) vs. Β-D-Glucan (BDG) for Preemptive Antifungal Stewardship in the Intensive Care Unit (ICU)
por: Gill, Christian, et al.
Publicado: (2018)

Efficacy and Safety of Combination Antifungals as Empirical, Preemptive, and Targeted Therapies for Invasive Fungal Infections in Intensive-Care Units
por: Yang, Qianting, et al.
Publicado: (2022)

Fungal Exocellular (1-6)-β-d-glucan: Carboxymethylation, Characterization, and Antioxidant Activity
por: Theis, Thais Vanessa, et al.
Publicado: (2019)

P392 Comparative evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal infections
por: Singh, Shreya, et al.
Publicado: (2022)

Platelet Parameters and (1, 3)-β-D-Glucan as a Diagnostic and Prognostic Marker of Invasive Fungal Disease in Preterm Infants
por: Zhao, Dongying, et al.
Publicado: (2015)

Pharmacokinetics, biological effects, and distribution of (1→3)-β-D-glucan in blood and organs in rabbits
por: Yoshida, Minoru, et al.
Publicado: (1997)

Fungal β-Glucan-Based Nanotherapeutics: From Fabrication to Application
por: Yang, Fan, et al.
Publicado: (2023)

Structure of a fungal 1,3-β-glucan synthase
por: Zhao, Chao-Ran, et al.
Publicado: (2023)

Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases
por: De Carolis, Elena, et al.
Publicado: (2020)

The Comparative Evaluation of the Fujifilm Wako β-Glucan Assay and Fungitell Assay for Diagnosing Invasive Fungal Disease
por: Singh, Shreya, et al.
Publicado: (2022)

Multidisciplinary approach to the treatment of invasive fungal infections in adult patients. Prophylaxis, empirical, preemptive or targeted therapy, which is the best in the different hosts?
por: Zaragoza, Rafael, et al.
Publicado: (2008)

418. Evaluation of β-d-Glucan (BG) and Galactomannan (GM) Detection Assays in the Diagnosis of Invasive Fungal Infections in High-Risk Pediatric Cancer Patients
por: Alali, Muayad, et al.
Publicado: (2018)

Diagnostic Efficacy of Serum 1,3-β-D-glucan for Invasive Fungal Infection: An Update Meta-Analysis Based on 37 Case Or Cohort Studies
por: Xiaoling, Lu, et al.
Publicado: (2018)

Role of (1-3)-Β-D-Glucan Test in the Diagnosis of Invasive Fungal Infections among High-Risk Patients in a Tertiary Care Hospital
por: Sandhar, Tanureet Kaur, et al.
Publicado: (2022)

Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1
por: Batbayar, Sainkhuu, et al.
Publicado: (2012)

Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence
por: Torosantucci, Antonella, et al.
Publicado: (2009)

Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis
por: Lamoth, Frédéric
Publicado: (2016)

Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses
por: McCarthy, Matthew W., et al.
Publicado: (2017)

Transglycosylation of Stevioside by a Commercial β-Glucanase with Fungal Extracted β-Glucans as Donors
por: Zerva, Anastasia, et al.
Publicado: (2023)

Utility of Intraocular Fluid β-D-glucan Testing in Fungal Endophthalmitis: A Series of 5 Cases
por: Chen, Li, et al.
Publicado: (2020)

An immunoassay for the measurement of (1→3)-β-D-glucans in the indoor environment
por: Douwes, Jeroen, et al.
Publicado: (1997)

Pneumocystis pneumonia diagnosed by repeated measurements of β-D-glucan levels
por: Kawasaki, Yasutaka, et al.
Publicado: (2023)

The Complexity of Fungal β-Glucan in Health and Disease: Effects on the Mononuclear Phagocyte System
por: Camilli, Giorgio, et al.
Publicado: (2018)

Interaction of oxalate with β-glucan: Implications for the fungal extracellular matrix, and metabolite transport
por: Perez-Gonzalez, Gabriel, et al.
Publicado: (2023)

Use of (1→3)‐β‐d‐glucan for diagnosis and management of invasive mycoses in HIV‐infected patients
por: Farhour, Zahra, et al.
Publicado: (2018)

Is (1→3)-β-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis?
por: Eggimann, Philippe, et al.
Publicado: (2011)

The fungal-specific β-glucan-binding lectin FGB1 alters cell-wall composition and suppresses glucan-triggered immunity in plants
por: Wawra, Stephan, et al.
Publicado: (2016)

P427 The value of nasal and oral clinical examination in febrile neutropenic patients for initiating anti-fungal therapy as a preemptive method
por: Sarvestani, Hasti Kamali, et al.
Publicado: (2022)

EphA2 is an epithelial cell pattern recognition receptor for fungal β-glucans
por: Swidergall, Marc, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vap62plg1e3ic7s6qadaggtepp